Better Therapeutics Inc (BTTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,740 | 40,566 | 123 | N/A | N/A |
| Other current assets | 210 | 276 | 216 | 0 | 0 |
| TOTAL | $18,446 | $45,251 | $463 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 121 | 82 | 89 | N/A | N/A |
| Other Non-Current Assets | 4,376 | 5,625 | 5,835 | 0 | 0 |
| TOTAL | $4,497 | $5,707 | $5,924 | $N/A | $N/A |
| Total Assets | $22,943 | $50,958 | $6,387 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,532 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,035 | 1,523 | 514 | 0 | 0 |
| Accrued Expenses | 5,927 | 3,210 | 99 | N/A | N/A |
| TOTAL | $13,494 | $4,733 | $613 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,348 | 9,505 | 640 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 11,740 | 0 | 0 |
| TOTAL | $10,348 | $9,505 | $12,532 | $N/A | $N/A |
| Total Liabilities | $23,842 | $14,238 | $13,145 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,852 | 23,609 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 1 | N/A | N/A |
| Retained earnings | -111,503 | -71,743 | -31,408 | N/A | N/A |
| TOTAL | $-899 | $36,720 | $-6,758 | $N/A | $N/A |
| Total Liabilities And Equity | $22,943 | $50,958 | $6,387 | $0 | $0 |